期刊文献+

犬尿氨酸代谢通路与中枢神经系统 被引量:5

The Kynurenine Metabolic Pathway and the Central Nervous System
原文传递
导出
摘要 犬尿氨酸代谢通路涉及一系列酶促反应,生成多种具有生物学活性的化合物,这些代谢产物统称为“犬尿氨酸能物质”。犬尿氨酸能物质参与多种病理生理学过程,在中枢神经系统中有着重要的生理功能。例如,喹啉酸是N-甲基-D-天冬氨酸受体激动剂,在许多感染性神经系统疾病中可大量堆积在中枢神经系统,导致神经元因兴奋性中毒而死亡。犬尿喹啉酸可拮抗兴奋性谷氨酸盐受体,减少因兴奋性中毒导致的神经元死亡。文章就犬尿氨酸代谢通路在中枢神经系统中作用的相关研究做了综述。 The kynurenine metabolic pathway involves in a cascade of enzyme reaction generated multiple biologically-active compounds, These metabolites are called "kynurenines", which participate in diverse pathophysiological processes, particularly in the central nervous system. The kynurenines have important physiological functions. For example, quinolinic acid is an N-methyl-D-aspartate (NMDA) receptor agonist, and it can be largely accumulated in the central ner^us system in many infectious nervous system diseases, resulting in neuronal excitotoxicity and death. Kynurenic acid antagonizes excitatory glutamate receptors to reduce excitotoxicityinduced neuronal death. This article reviews the related researches of the effects of kynurenine metabolic pathway on the central nervous system.
出处 《国际脑血管病杂志》 2008年第5期388-392,共5页 International Journal of Cerebrovascular Diseases
基金 国家重点基础研究发展计划“973”(No.2004CB518603) 国家自然科学基金(No.30600243)
关键词 犬尿氨酸 犬尿喹啉酸 喹啉酸 中枢神经系统 kynurenine kynurenic acid quinolinic acid central nervous system
  • 相关文献

参考文献30

  • 1Dairam A, Muller AC, Daya S. Non-steroidal anti-inflammatory agents, tolmetin and sulindac attenuate quinolinic acid (QA)-induced oxidative stress in primary hippocampal neurons and reduce QA-induced spatial reference memory deficits in male Wistar rats. Life Sci, 2007, 80: 1431 - 1438.
  • 2Guidetti P, Schwarcz R 3-Hydroxykynyrenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Adv Exp Med Biol, 2003, 527:137 - 145.
  • 3Guidetti P, Bates GP, Graham RK, et al. Elevated brain 3- hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiol Dis, 2006, 23:190 - 197.
  • 4Shepard PD, Joy B, Clerkin L, et al. Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat. Neuropsychopharmacology, 2003, 28:1454 - 1462.
  • 5Ohno M, Yamamoto T, Watanabe S. Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats. Eur J Pharrnacol, 1994, 253:183 -187.
  • 6Santamaria A, Flores-Escartin A, Martinez JC, et al. Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med, 2003, 35:418 -427.
  • 7Santamaria A, Salvatierra-Sanchez R, Vazquez-Roman B, et al. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem, 2D03,86:479 -488.
  • 8Pellicciari R, Natalini B, Costantino G, et al. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hyckoxylase. J Med Chem, 1994, 37:647 -655.
  • 9Varasi M, Della Torre A, Heidempergher F, et al. Derivatives of kynurenine as inhibitors of rat brain kynurenine aminotransferase. Eur J Med Chem, 1996, 31:11 -21.
  • 10Guillemin GJ, Croitoru-Lamoury J, Dormont D, et al. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia, 2003,41 : 371 - 381.

二级参考文献11

  • 1Zhu DL, Wang HY, Xiong MM, et al. Linkage of hypertension to chromosome 2q14-q23 in Chinese families. J Hypertens, 2001, 19: 55-61.
  • 2Harrap SB. Where are all the blood-pressure gene? Lancet, 2003,361: 2149-2151.
  • 3Stoll M, Kwitek-Black AE, Cowley AW Jr, et al. New target regions for human hypertension via comparative genomics. Genome Res, 2000,10: 473-482.
  • 4Moses EK, Lade JA, Guo G, et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet, 2000, 67: 1581-1585.
  • 5Newman DL, Abney M, Dytch H, et al. Major loci in.uencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree, Hum Mol Genet. 2003,12: 137-144.
  • 6Pajukanta P, Cargill M, Viitanen L, et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet,2000,67: 1481-1493.
  • 7Alberati-Giani D, Buchli R, Malherbe P, et al. Isolation and expression of a cDNA clone encoding human kynureninase. Europ J Biochem, 1996,239: 460-468.
  • 8Toma S,Nakamura M,Tone S, et al. Cloning and recombinant expression of rat and human kynureninase. FEBS Lett, 1997,408: 5-10.
  • 9Kapoor V, Kapoor R, Chalmers J. Kynurenic acid, an endogenous glutamate antagonist, in SHR and WKY rats: possible role in central blood pressure regulation. Clin Exp Pharmacol Physiol, 1994,21: 891-896.
  • 10Lapin IP. Depressor effect of kynurenine and its metabolites in rats. Life Sci, 1976,19: 1479-1483.

共引文献7

同被引文献97

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部